MOKO SOCIAL MEDIA LTD | Sales 2022 | 0.01 0.02 1.13 | Sales 2023 | 0.02 0.04 2.04 | Capitalization | 27.65L 41.72L 23Cr |
|---|---|---|---|---|---|
| Net income 2022 | -70L -1.06Cr -58Cr | Net income 2023 | -10L -15.09L -8.3Cr | EV / Sales 2022 | 43,52,05,817 x |
| Net Debt 2022 | 17.63L 26.6L 15Cr | Net Debt 2023 | 22.77L 34.36L 19Cr | EV / Sales 2023 | 20,49,57,276 x |
| P/E ratio 2022 |
-0.53
x | P/E ratio 2023 |
-1.82
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 0% |
More Fundamentals
* Assessed data
| Managers | Title | Age | Since |
|---|---|---|---|
Glenn Tong
CEO | Chief Executive Officer | - | 19/19/19 |
Ian Forbes
DFI | Director of Finance/CFO | - | 20/20/20 |
David Kingston
CTO | Chief Tech/Sci/R&D Officer | - | 11/20/11 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Louis Panaccio
CHM | Chairman | 67 | 28/19/28 |
Jia Yi Yu
BRD | Director/Board Member | - | 28/19/28 |
Glenn Tong
CEO | Chief Executive Officer | - | 19/19/19 |
Azure Health Technology Ltd is an Australia-based biotechnology company. The Company is developing and commercializing dietary supplements and prescription medicines based on tocotrienols. Tocotrienols is a natural product, which is having therapeutic potential, including Delayed Onset Muscle Soreness, muscle recovery, exercise endurance, Non-Alcoholic Fatty Liver Disease (NAFLD), Non-Alcoholic SteatoHepatitis (NASH), pancreatic cancer, hyperlipidaemia, hypertension and diabetes. The Company has a product development program for evidence-based nutraceuticals and a clinical development program for prescription medicines.
Sector
-
